Kentuckiana Pulmonary Association

Louisville, Kentucky 40202

0 studies enrolling now · 2 studies all time

What they study most

Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension

Studies at this site

• ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis — Stopped early
• (ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF — Stopped early